9229 Stock Overview
Sunwels Co.,Ltd. operates nursing care business centered on PD house.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 6/6 |
Past Performance | 6/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Sunwels Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥2,238.00 |
52 Week High | JP¥3,880.00 |
52 Week Low | JP¥2,014.00 |
Beta | 0 |
1 Month Change | -18.35% |
3 Month Change | -2.70% |
1 Year Change | -28.73% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 139.79% |
Recent News & Updates
Market Participants Recognise Sunwels Co.,Ltd.'s (TSE:9229) Earnings Pushing Shares 28% Higher
Feb 28Shareholder Returns
9229 | JP Healthcare | JP Market | |
---|---|---|---|
7D | -3.7% | 0.8% | 2.5% |
1Y | -28.7% | 3.5% | 29.1% |
Return vs Industry: 9229 underperformed the JP Healthcare industry which returned 3.5% over the past year.
Return vs Market: 9229 underperformed the JP Market which returned 29.1% over the past year.
Price Volatility
9229 volatility | |
---|---|
9229 Average Weekly Movement | 6.9% |
Healthcare Industry Average Movement | 3.7% |
Market Average Movement | 4.2% |
10% most volatile stocks in JP Market | 8.1% |
10% least volatile stocks in JP Market | 2.3% |
Stable Share Price: 9229's share price has been volatile over the past 3 months.
Volatility Over Time: 9229's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 1,747 | Ryotatsu Nawashiro | sunwels.jp |
Sunwels Co.,Ltd. operates nursing care business centered on PD house. It operates homes for the elderly that specializes in Parkinson disease, as well as a Kaatsu training gym; provides day care, in-home care support, care plan, and home remodeling services; and operates medical specific facilities.
Sunwels Co.,Ltd. Fundamentals Summary
9229 fundamental statistics | |
---|---|
Market cap | JP¥67.06b |
Earnings (TTM) | JP¥1.74b |
Revenue (TTM) | JP¥19.34b |
38.9x
P/E Ratio3.5x
P/S RatioIs 9229 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
9229 income statement (TTM) | |
---|---|
Revenue | JP¥19.34b |
Cost of Revenue | JP¥13.64b |
Gross Profit | JP¥5.70b |
Other Expenses | JP¥3.97b |
Earnings | JP¥1.74b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
Earnings per share (EPS) | 57.47 |
Gross Margin | 29.49% |
Net Profit Margin | 8.98% |
Debt/Equity Ratio | 79.4% |
How did 9229 perform over the long term?
See historical performance and comparison